SCHEMBL26633914

SCHEMBL26633914

COc1ccc(CNC(=O)NC2CC3(C2)CC(C(=O)N2CCN(C(=O)c4ccccc4)CC2)C3)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ ALDH1A1 P00352 3/20 0.48
▸ MAPK8 P45983 1/20 0.48
▸ MAPK10 P53779 1/20 0.48
▸ ACHE P22303 2/20 0.47
▸ BACE1 P56817 2/20 0.47
▸ HRH3 Q9Y5N1 3/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ IGF1R P08069 1/20 0.46
▸ FGFR1 P11362 1/20 0.46
▸ BRAF P15056 1/20 0.46
▸ FGFR2 P21802 1/20 0.46
▸ FGFR4 P22455 1/20 0.46
▸ FGFR3 P22607 1/20 0.46
▸ JAK1 P23458 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ AXL P30530 1/20 0.46
▸ CDK5 Q00535 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011342 0.90 NPC1 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1MAPK8
SCHEMBL26633880 0.88 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL26633940 0.88 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL26633710 0.87 NPC1 (0.56) NPC1RAB9ASMN1; SMN2ALDH1A1MAPK8
SCHEMBL26633886 0.86 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL26633750 0.85 NPC1 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL30306687 0.85 NPC1 (0.54) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL24011198 0.85 NPC1 (0.64) NPC1RAB9ASMN1; SMN2ALDH1A1ACHE
SCHEMBL26633881 0.85 RAB9A (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3
SCHEMBL26633697 0.85 SMN1; SMN2 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT NPC1 128/4885RAB9A 814/4885SMN1; SMN2 610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback